BIT
TGTX icon

BlackRock Institutional Trust’s TG Therapeutics TGTX Stock Holding History

BlackRock Institutional Trust’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$4.5M Buy
968,608
+14,656
+2% +$85.9K ﹤0.01% 2768
2016
Q3 		$7.38M Buy
953,952
+54,213
+6% +$349K ﹤0.01% 2525
2016
Q2 		$5.45M Sell
899,739
-26,968
-3% -$219K ﹤0.01% 2636
2016
Q1 		$7.9M Buy
926,707
+29,898
+3% +$262K ﹤0.01% 2419
2015
Q4 		$10.7M Buy
896,809
+28,713
+3% +$363K ﹤0.01% 2281
2015
Q3 		$8.75M Buy
868,096
+124,990
+17% +$1.86M ﹤0.01% 2379
2015
Q2 		$12.3M Buy
743,106
+9,504
+1% +$150K ﹤0.01% 2267
2015
Q1 		$11.4M Buy
733,602
+219,161
+43% +$3.32M ﹤0.01% 2318
2014
Q4 		$8.15M Buy
514,441
+288,699
+128% +$3.76M ﹤0.01% 2479
2014
Q3 		$2.41M Sell
225,742
-18,453
-8% -$171K ﹤0.01% 2998
2014
Q2 		$2.29M Buy
244,195
+76,612
+46% +$490K ﹤0.01% 3131
2014
Q1 		$1.16M Buy
167,583
+30,320
+22% +$179K ﹤0.01% 3373
2013
Q4 		$535K Sell
137,263
-25,969
-16% -$105K ﹤0.01% 3565
2013
Q3 		$823K Buy
163,232
+38,038
+30% +$233K ﹤0.01% 3410
2013
Q2 		$800K Buy
+125,194
New +$802K ﹤0.01% 3390

Other funds holding TGTX

BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock Institutional Trust's TGTX Position: Q4 2016 in Review

BlackRock Institutional Trust increased its TG Therapeutics (TGTX) stake by 1.5% in Q4 2016, buying an estimated $85.9K and bringing the position to 968,608 shares worth $4.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2768.

BlackRock Institutional Trust first reported a position in TGTX in Q2 2013 and has held it in 15 quarters since. The position peaked at $12.3M in Q2 2015. 91 funds tracked by Wall St. Rank hold TGTX as of Q4 2016.

  • BlackRock Institutional Trust held 968,608 shares of TG Therapeutics worth $4.5M as of Q4 2016.
  • BlackRock Institutional Trust bought 14,656 TG Therapeutics shares in Q4 2016, an estimated $85.9K.
  • TG Therapeutics made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2768 holding.
  • BlackRock Institutional Trust first reported a position in TG Therapeutics in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's TG Therapeutics position peaked at $12.3M in Q2 2015.
  • 91 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.